569 related articles for article (PubMed ID: 11923550)
1. Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.
Rorke S; Jennison S; Jeffs JA; Sampson AP; Arshad H; Holgate ST
Thorax; 2002 Apr; 57(4):323-7. PubMed ID: 11923550
[TBL] [Abstract][Full Text] [Related]
2. Leukotriene E
Lazarinis N; Bood J; Gomez C; Kolmert J; Lantz AS; Gyllfors P; Davis A; Wheelock CE; Dahlén SE; Dahlén B
J Allergy Clin Immunol; 2018 Oct; 142(4):1080-1089. PubMed ID: 29518425
[TBL] [Abstract][Full Text] [Related]
3. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist.
Reiss TF; Hill JB; Harman E; Zhang J; Tanaka WK; Bronsky E; Guerreiro D; Hendeles L
Thorax; 1997 Dec; 52(12):1030-5. PubMed ID: 9516894
[TBL] [Abstract][Full Text] [Related]
4. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin A-induced bronchoconstriction.
Crimi N; Pagano C; Palermo F; Mastruzzo C; Prosperini G; Pistorio MP; Vancheri C
J Allergy Clin Immunol; 2003 Apr; 111(4):833-9. PubMed ID: 12704366
[TBL] [Abstract][Full Text] [Related]
6. [Single dose of montelukast as an effective prevention of post exercise bronchospasm in children with bronchial asthma].
Gaszczyk G; Latoś T; Słowikowski A; Janiak B
Med Wieku Rozwoj; 2004; 8(3 Pt 2):847-56. PubMed ID: 15858257
[TBL] [Abstract][Full Text] [Related]
7. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
[TBL] [Abstract][Full Text] [Related]
8. Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma.
Mastalerz L; Gawlewicz-Mroczka A; Nizankowska E; Cmiel A; Szczeklik A
Clin Exp Allergy; 2002 Sep; 32(9):1360-5. PubMed ID: 12220476
[TBL] [Abstract][Full Text] [Related]
9. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
De Lepeleire I; Reiss TF; Rochette F; Botto A; Zhang J; Kundu S; Decramer M
Clin Pharmacol Ther; 1997 Jan; 61(1):83-92. PubMed ID: 9024176
[TBL] [Abstract][Full Text] [Related]
10. Sodium cromoglycate alone and in combination with montelukast on the airway response to mannitol in asthmatic subjects.
Anderson SD; Brannan JD; Perry CP; Caillaud C; Seale JP
J Asthma; 2010 May; 47(4):429-33. PubMed ID: 20528598
[TBL] [Abstract][Full Text] [Related]
11. Exercise-induced bronchoconstriction in children: montelukast attenuates the immediate-phase and late-phase responses.
Melo RE; Solé D; Naspitz CK
J Allergy Clin Immunol; 2003 Feb; 111(2):301-7. PubMed ID: 12589349
[TBL] [Abstract][Full Text] [Related]
12. Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.
Reiss TF; Altman LC; Chervinsky P; Bewtra A; Stricker WE; Noonan GP; Kundu S; Zhang J
J Allergy Clin Immunol; 1996 Sep; 98(3):528-34. PubMed ID: 8828530
[TBL] [Abstract][Full Text] [Related]
13. Cysteinyl leukotriene antagonism inhibits bronchoconstriction in response to hypertonic saline inhalation in asthma.
Kazani S; Sadeh J; Bunga S; Wechsler ME; Israel E
Respir Med; 2011 May; 105(5):667-73. PubMed ID: 21169002
[TBL] [Abstract][Full Text] [Related]
14. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast.
Rabinovitch N; Strand M; Stuhlman K; Gelfand EW
J Allergy Clin Immunol; 2008 Jun; 121(6):1365-71. PubMed ID: 18439662
[TBL] [Abstract][Full Text] [Related]
15. Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction.
Kim JH; Lee SY; Kim HB; Kim BS; Shim JY; Hong TJ; Hong SJ
Pediatr Pulmonol; 2005 Feb; 39(2):162-6. PubMed ID: 15633203
[TBL] [Abstract][Full Text] [Related]
16. Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise.
Rundell KW; Spiering BA; Baumann JM; Evans TM
Br J Sports Med; 2005 Apr; 39(4):232-6. PubMed ID: 15793094
[TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group.
Altman LC; Munk Z; Seltzer J; Noonan N; Shingo S; Zhang J; Reiss TF
J Allergy Clin Immunol; 1998 Jul; 102(1):50-6. PubMed ID: 9679847
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory basis of exercise-induced bronchoconstriction.
Hallstrand TS; Moody MW; Wurfel MM; Schwartz LB; Henderson WR; Aitken ML
Am J Respir Crit Care Med; 2005 Sep; 172(6):679-86. PubMed ID: 15947280
[TBL] [Abstract][Full Text] [Related]
19. Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.
Muijsers RB; Noble S
Paediatr Drugs; 2002; 4(2):123-39. PubMed ID: 11888359
[TBL] [Abstract][Full Text] [Related]
20. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.
Williams B; Noonan G; Reiss TF; Knorr B; Guerra J; White R; Matz J
Clin Exp Allergy; 2001 Jun; 31(6):845-54. PubMed ID: 11422148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
